Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia

NCT03413462 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

374

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: HS-25
DRUG: Placebo of HS-25

Sponsor

Zhejiang Hisun Pharmaceutical Co. Ltd.